GlaxoSmithKline Pharmaceuticals Limited — Dividend/Bonus, 13-05-2026: Dividend

The Board has approved a proposal for a final dividend of Rs. 57 per equity share for the fiscal year. This significant payout awaits shareholder approval at the upcoming Annual General Meeting. Investors holding shares by the designated record date will be eligible for the dividend, with payments expected to commence shortly after AGM clearance. This directly enhances shareholder returns.